Waldenstrom Macroglobulinemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-05-23
Clinical Trial Update: Loncastuximab Tesirine in WM [Phase 2]
A Phase 2 clinical trial assessing Loncastuximab tesirine for Waldenström macroglobulinemia is currently recruiting.